EP0419890A2 — Stable pharmaceutical formulations for antineoplastic compounds having more than one ethyleneimine group, and method
Assigned to Wyeth Holdings LLC · Expires 1991-04-03 · 35y expired
What this patent protects
Preconstituted pharmaceutical compositions comprising antineoplastic compounds having more than one ethyleneimine group are provided by adding a water-free, water-miscible, neutral or basic, oxygen containing pharmaceutically acceptable solvent. Such compositions remain stable fo…
USPTO Abstract
Preconstituted pharmaceutical compositions comprising antineoplastic compounds having more than one ethyleneimine group are provided by adding a water-free, water-miscible, neutral or basic, oxygen containing pharmaceutically acceptable solvent. Such compositions remain stable for prolonged periods under refrigerated conditions and are reconstitutable in water or other I.V. diluents to provide injectable dosage forms.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.